Skip Navigation Links
   
Skip Navigation Links
   

Lung Cancer - Adjuvant (Advanced Unresectable)


Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer (Erlotinib Hydrochloride and Crizotinib Provided)  RTOG 1306 (NCT01822496)   (MBMC Contact: Missy Kuhn 314-996-5868 (Open at MBMC:  RTOG Credentialing Required for Affiliate Sites Prior to Patient Registration - See Protocol)

A dose finding study followed by Phase II randomized, placebo-controlled study of veliparib (ABT-888) added to chemoradiotherapy with carboplatin and paclitaxel for unresectable non-small cell lung cancer  SWOG 1206/8811 (NCT01386385)  (MBMC Contact:  Missy Kuhn 314-996-5868)

 

 

Melanoma Trials in St. Louis, MO
 
 

All contents 2007 Heartland Cancer Research St. Louis, MO. All rights reserved. Privacy Policy